MEDICARE LOCAL COVERAGE DETERMINATION (LCD) - L35526 CPT CODES: 83880 B-TYPE NATRIURETIC PEPTIDE (BNP) DLS TEST CODE AND NAME Source: www.cms.hhs.gov/mcd Effective Date: 10-1-2016, last updated 10-1-2019 B-type Natriuretic Peptide 1 of 2
83880 Assay of NATRIURETIC PEPTIDE BNP Test (CPT 83880) One of the below diagnosis must be present to support medical necessity for B-Type Natriuretic Peptide (BNP) Testing. I-10 Code Description
This article contains coding and other guidelines that complement the Local Coverage Determination (LCD) for B-type Natriuretic Peptide (BNP) Testing Procedure codes may be subject to National Correct Coding Initiative (NCCI) edits or OPPS packaging edits.
B-type Natriuretic Peptide (BNP) Local Coverage Determination. CPT Code: 83880 . Code Description I11.0 Hypertensive heart disease with heart failure I13.0
ICD-10-CM Diagnosis Code R97 R97.
BNP is not covered: As a stand-alone test, without being used in conjunction with standard diagnostic tests, medical history and clinical findings; For monitoring the efficiency of treatment for CHF and in tailoring the therapy for heart failure; For adjustment of therapy in individual patients, or.
One of the below diagnosis must be present to support medical necessity for B-Type Natriuretic Peptide (BNP) Testing. Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle.
B‐type natriuretic peptide, which is also called brain‐type natriuretic peptide (BNP), was first described in 1988 after isolation from porcine brain. However, it was soon found to originate mainly from the heart, representing a cardiac hormone.
ICD-10-CM Codes that Support Medical Necessity The CPT code 83880 may be used for BNP or NT-proBNP testing.
ICD-10 Code for Systolic (congestive) heart failure- I50. 2- Codify by AAPC.
Brain natriuretic peptide (BNP) test is a blood test that measures levels of a protein called BNP that is made by your heart and blood vessels. BNP levels are higher than normal when you have heart failure.
Natriuretic peptides are substances made by the heart. Two main types of these substances are brain natriuretic peptide (BNP) and N-terminal pro b-type natriuretic peptide (NT-proBNP). Normally, only small levels of BNP and NT-proBNP are found in the bloodstream.
A: When physicians use a prothrombin time test (reported with CPT code 85610) to monitor patients on anticoagulant drugs, Medicare pays the entity that performed the test. Its payment for the test is based on the geographically specific laboratory test fee schedule.
BNP is a risk stratification tool used to assess risk of death, myocardial infarction or CHF among patients with acute coronary syndrome (myocardial infarction with or without T-wave elevation and unstable angina).
The sensitivity of BNP in heart failure is approximately 97%. Therefore a normal BNP level (less than 100 pg/ml) virtually excludes heart failure and should prompt a search for noncardiac causes of dyspnea.
Regardless of age or gender, a BNP level of 100 pg/mL or less is considered normal. The higher your level goes above that, the higher your chances are of developing heart failure. Other conditions, like kidney disease, can increase these chances even more.
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
Language quoted from the Centers for Medicare and Medicaid Services (CMS) National Coverage Determinations (NCDs) and coverage provisions in interpretive manuals is italicized throughout the policy.
The following coding and billing guidance is to be used with its associated Local coverage determination.
It is the responsibility of the provider to code to the highest level specified in the ICD-10-CM (e.g., to the third to seventh character). The correct use of an ICD-10-CM code listed below does not assure coverage of a service.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
CPT codes, descriptions and other data only are copyright 2021 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
This article contains coding and other guidelines that complement the Local Coverage Determination (LCD) for B-type Natriuretic Peptide (BNP) Testing
The correct use of an ICD-10-CM code listed below does not assure coverage of a service. The service must be reasonable and necessary in the specific case and must meet the criteria specified in this determination. The CPT code 83880 may be used for BNP or NT-proBNP testing.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It is secreted in response to ventricular volume expansion and pressure overload, conditions often present in congestive heart failure (CHF).
Since BNP is a point of service test, the primary outpatient site of service expected to perform a serum BNP is the emergency room or a physician’s office.
BNP measurements may be considered reasonable and necessary when used in combination with other medical data such as medical history, physical examination, laboratory studies, and chest x-ray.
Serum BNP, for the purposes of coverage, is considered a ‘point-of-service test (performed and immediately used in the disposition of patient care). Serum BNP, when used in conjunction with other clinical information, will be considered reasonable and necessary for the following:
However, the assessment of BNP level has not been shown to alter patient management. The BNP is not sufficiently sensitive to either preclude or necessitate any other evaluation or treatment in this group of patients. •Screening examinations are statutorily non-covered.
B-type natriuretic peptide (BNP), also referred to as brain natriuretic peptide, is a member of a family of structurally similar peptide hormones that includes atrial natriuretic peptide. 1 BNP is a 32-amino-acid peptide that contains a 17-amino-acid ring structure that is formed as the result of an internal disulfide bond. BNP is predominantly secreted by the ventricles of the heart in response to increased pressure. BNP acts as a vasodilator and has diuretic and natriuretic properties. BNP suppresses both sympathetic tone and the renin-angiotensin system. These physiologic effects serve to reduce intraventricular pressure and improve the symptoms of congestive heart failure (CHF).
BNP is predominantly secreted by the ventricles of the heart in response to increased pressure. BNP acts as a vasodilator and has diuretic and natriuretic properties. BNP suppresses both sympathetic tone and the renin-angiotensin system.